The Protective Effect of Naringenin on Airway Remodeling after Mycoplasma Pneumoniae Infection by Inhibiting Autophagy-Mediated Lung Inflammation and Fibrosis
Table 1
Characteristics of subjects in the study.
Demographic characteristics
Non-Mycoplasma pneumoniae () (%)
Mycoplasma pneumoniae () (%)
Sex
Female
34 (53%)
38 (63%)
Male
30 (47%)
22 (37%)
Age
1–3 years
5 (7.8%)
4 (6.7%)
3–7 years
41 (64.1%)
32 (53.3%)
7–14 years
18 (28.1%)
24 (40%)
Average age
6.51 ± 2.85
7.01 ± 2.80
Whole blood cell analysis
White blood cell (×109)
10.82 ± 2.38
11.23 ± 3.24
Neutrophils (%)
28.79 ± 13.24
37.38 ± 12.68
Lymphocytes (%)
61.28 ± 14.26
57.36 ± 16.38
Blood platelet (×109)
375.9 ± 132.7
399.8 ± 142.8
Expression of mammary immune-associated factors
IL-1β (pg/ml)
23.67 ± 6.35
67 ± 11.33
IL-6 (pg/ml)
46.58 ± 8.67
95 ± 16.23
TNF-α (pg/ml)
56.34 ± 8.33
128.98 ± 14.27
TGF-β (pg/ml)
16.87 ± 5.34
32.45 ± 8.62
IL-17: interleukin- (IL-) 17; IL-1β: interleukin- (IL-) 1β; IL-6: interleukin- (IL-) 6; TNF-α: tumor necrosis factor-α; TGF-β: transforming growth factor-β. Data are expressed as mean ± SD with Student’s t-test analysis. ,, against the control values.
